Naperville, IL -- (SBWIRE) -- 10/03/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018 market report to its offering
About COPD:
COPD is a broad term that covers various progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It is a serious condition that restricts airflow in the lungs and is characterized by increasing breathlessness. The exact etiology of COPD is not understood; however, most cases of COPD are caused due to genetic factors and by inhaling pollutants, including fumes and chemicals. The disease cannot be cured; it can be only be managed and treated.
Analysts forecast the Global COPD market to grow at a CAGR of 5.69 percent over the period 2013-2018.
Covered in this Report:
This report covers the present scenario and the growth prospects of the Global COPD market for the period 20142018. To calculate the market size, the report considers the revenue generated from the sales of various drugs in the form of oral medications as well as inhalers for the treatment of COPD. The Global COPD market can be segmented into five: Medications, Oxygen Therapy, Surgery, Pulmonary Rehabilitation, and Lifestyle Changes.
Global COPD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global COPD market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions:
Americas
APAC
EMEA
Key Vendors:
Astra Zeneca
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Pfizer
Other Prominent Vendors:
Alere
Almirall
Astellas Pharma
Axis Shield
Beckton Dckinson
Biosensors International
Dainippon Sumitomo Pharma
Medtronic
Merck
Mylan
Novartis
Siemens Healthcare Diagnostics
Takeda Pharmaceutical
Theravance
Market Driver:
Elderly Population
For a full, detailed list, view our report
Market Challenge:
High Cost of COPD Treatment
For a full, detailed list, view our report
Market Trend:
Increase in Awareness of COPD
For a full, detailed list, view our report
Key Questions Answered in this Report:
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Companies Mentioned:
Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Pfizer , Alere , Almirall , Astellas Pharma , Axis Shield, Beckton Dckinson , Biosensors International , Dainippon Sumitomo Pharma , Medtronic , Merck, Mylan, Novartis, Siemens Healthcare Diagnostics , TakedaPharmaceutical, Theravance
Complete report is available
http://www.reportstack.com/product/175179/global-chronic-obstructive-pulmonary-disease-copd-market-2014-2018.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604